ARCHIVES

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

This article is from The Cancer Letter archive.

Vol. 38 No. 38 | October 12, 2012

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Imaging Technique Identifies Consequences Of Mutation

February 24, 2012

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988